Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents - PubMed (original) (raw)
. 1994 Jun 15;57(6):920-5.
doi: 10.1002/ijc.2910570624.
Affiliations
- PMID: 7515861
- DOI: 10.1002/ijc.2910570624
Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents
B A Teicher et al. Int J Cancer. 1994.
Abstract
The ability of TNP-470, a synthetic analog of fumagillin which has been described as an anti-angiogenic agent, to potentiate cytotoxic cancer therapies was investigated in vivo in the murine FSaIIC fibrosarcoma and the Lewis lung carcinoma. TNP-470 was more toxic toward FSaIIC tumor cells from tumors treated in vivo than toward bone-marrow CFU-GM from the same animals. TNP-470 had a dose-modifying effect on the toxicity of cyclophosphamide toward FSaIIC tumor cells which amounted to an 8-fold increase in tumor-cell killing at a cyclophosphamide dose of 500 mg/kg. Treatment with TNP-470 and minocycline increased the permeability of the FSaII fibrosarcoma in vivo to the fluorescent dye Hoechst 33342 and increased the killing of both the bright and the dim tumor cells by cyclophosphamide. TNP-470, especially in combination with minocycline, formed a highly effective modulator combination for treatment of the Lewis lung carcinoma with cytotoxic cancer therapies against primary and metastatic disease. The combination of TNP-470/minocycline and cyclophosphamide led to 40 to 50% long-term survivors in Lewis-lung-carcinoma-bearing animals. Our results indicate that the use of anti-angiogenic modulators in cancer therapy is a very promising area for further study.
Similar articles
- Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.
Teicher BA, Holden SA, Dupuis NP, Kakeji Y, Ikebe M, Emi Y, Goff D. Teicher BA, et al. Breast Cancer Res Treat. 1995;36(2):227-36. doi: 10.1007/BF00666043. Breast Cancer Res Treat. 1995. PMID: 8534870 - Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents.
Kakeji Y, Teicher BA. Kakeji Y, et al. Invest New Drugs. 1997;15(1):39-48. doi: 10.1023/a:1005718628223. Invest New Drugs. 1997. PMID: 9195288 - TNP-470 (AGM-1470): mechanisms of action and early clinical development.
Castronovo V, Belotti D. Castronovo V, et al. Eur J Cancer. 1996 Dec;32A(14):2520-7. doi: 10.1016/s0959-8049(96)00388-7. Eur J Cancer. 1996. PMID: 9059342 Review. No abstract available. - TNP-470/minocycline/cytotoxic therapy: a systems approach to cancer therapy.
Teicher BA, Emi Y, Kakeji Y, Northey D. Teicher BA, et al. Eur J Cancer. 1996 Dec;32A(14):2461-6. doi: 10.1016/s0959-8049(96)00380-2. Eur J Cancer. 1996. PMID: 9059334 Review. No abstract available.
Cited by
- Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.
Pomella S, Porrazzo A, Cassandri M, Camero S, Codenotti S, Milazzo L, Vulcano F, Barillari G, Cenci G, Marchese C, Fanzani A, Megiorni F, Rota R, Marampon F. Pomella S, et al. Int J Mol Sci. 2022 Oct 31;23(21):13281. doi: 10.3390/ijms232113281. Int J Mol Sci. 2022. PMID: 36362070 Free PMC article. Review. - Targeting hallmarks of cancer to enhance radiosensitivity in gastrointestinal cancers.
Buckley AM, Lynam-Lennon N, O'Neill H, O'Sullivan J. Buckley AM, et al. Nat Rev Gastroenterol Hepatol. 2020 May;17(5):298-313. doi: 10.1038/s41575-019-0247-2. Epub 2020 Jan 31. Nat Rev Gastroenterol Hepatol. 2020. PMID: 32005946 Review. - Targeting Metalloenzymes for Therapeutic Intervention.
Chen AY, Adamek RN, Dick BL, Credille CV, Morrison CN, Cohen SM. Chen AY, et al. Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7. Chem Rev. 2019. PMID: 30192523 Free PMC article. Review. - Overcoming key biological barriers to cancer drug delivery and efficacy.
Kim SM, Faix PH, Schnitzer JE. Kim SM, et al. J Control Release. 2017 Dec 10;267:15-30. doi: 10.1016/j.jconrel.2017.09.016. Epub 2017 Sep 14. J Control Release. 2017. PMID: 28917530 Free PMC article. Review. - Clinical Significance of Serum IL-12 Level in Patients with Early Breast Carcinoma and Its Correlation with Other Tumor Markers.
Youssef SS, Mohammad MM, Ezz-El-Arab LR. Youssef SS, et al. Open Access Maced J Med Sci. 2015 Dec 15;3(4):640-4. doi: 10.3889/oamjms.2015.106. Epub 2015 Nov 3. Open Access Maced J Med Sci. 2015. PMID: 27275301 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources